GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: The Journal of Clinical Endocrinology & Metabolism, The Endocrine Society, Vol. 97, No. 1 ( 2012-01), p. E1-E13
    Type of Medium: Online Resource
    ISSN: 0021-972X , 1945-7197
    RVK:
    Language: English
    Publisher: The Endocrine Society
    Publication Date: 2012
    detail.hit.zdb_id: 2026217-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 71, No. 8_Supplement ( 2011-04-15), p. 4781-4781
    Abstract: The inhibitor of apoptosis protein (IAP) family member, X-linked Inhibitor of Apoptosis Protein (XIAP) is essential for cell survival in variety of cancers. However, the role of XIAP overexpression in papillary thyroid carcinoma (PTC) is not fully elucidated. Therefore, we analyzed the expression of XIAP protein and its clinico-pathological correlation in a large cohort of Middle Eastern PTC by immuno-histochemistry in a tissue micro-array format followed by in vitro studies using PTC cell lines. XIAP was found to be over-expressed in 25% of PTC and directly associated with older age (p & lt;0.0001) and presence of extra-thyroidal extension (p & lt;0.0001). Interestingly, XIAP was also found to be significantly associated with tall-cell variant (p=0.0013), larger tumor size (p=0.0002) and advanced stage (III and IV) disease (p & lt; 0.0001). XIAP over-expression was also significantly associated with over-expression of oncogenic c-Met (p=0.0010) and anti-apoptotic Bcl-Xl protein (p & lt;0.0001). Finally, PTC with XIAP over-expression showed a significantly poor disease free survival (p=0.0476) of 63.1 months as compared to the PTC's with low XIAP expression (74.0 months). Our in vitro data showed that embelin, a selective inhibitor of XIAP, caused a dose dependent inhibition of cell proliferation in PTC cell lines. Furthermore, we found that embelin induced a dose dependent apoptosis as detected by cell cycle analysis and annexin V/PI dual staining in PTC cells. On further analysis, our data showed that embelin induced a caspase-dependent apoptosis of PTC cells via activation and cleavage of capsases-9 and -3 and cleavage of PARP. In summary, our clinical data highlights the fact that XIAP over-expression in PTC confer a aggressive phenotype with poor outcome. In vitro studies using XIAP inhibitor suggest that this sub-group of PTC with over-expression of XIAP can be therapeutically targeted to induce efficient apoptosis in these cancers. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 4781. doi:10.1158/1538-7445.AM2011-4781
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2011
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 71, No. 8_Supplement ( 2011-04-15), p. 2602-2602
    Abstract: The FoxM1 transcription factor promotes the pathogenesis of several malignancies. However, little is known about its expression and function in papillary thyroid cancers (PTC). In the present study we investigated the role of FoxM1 in the pathogenesis of PTC in a large series of PTC in a tissue micro array (TMA) format followed by studies using PTC cell lines and nude mice. Our data showed that expression of FoxM1 was over expressed in 28.4 % (141/496) of PTC and significantly associated with activated AKT (p & lt;0.0001) and matrix metalloproteinase-9 (MMP-9) expression (p=0.0004). FoxM1 over expression was also strongly associated with antiapoptotic markers, XIAP (p=0.0024), and Bcl-Xl (p=0.0014). In vitro data using PTC cell lines showed that inhibition of FoxM1 by thiostrepton resulted in inhibition of proliferation and induction of apoptosis in a dose dependent manner. In addition, thiostrepton treatment caused downregulation of SKP2, and consequent increase expression of p21 in PTC cell lines. We also found that down-regulation of FoxM1 reduced the expression of MMP-2, MMP-9 and vascular endothelial growth factor, resulting in the inhibition of migration, invasion, and angiogenesis in PTC cells. Furthermore, pharmacological inhibition of FoxM1 or siRNA targeted against FoxM1 triggered caspase dependent apoptosis in PTC cells. Finally, treatment of PTC cell line xenografts with thiostrepton resulted in growth inhibition of tumors in nude mice via downregulation of FoxM1 and MMP9. Altogether, our results suggest that FoxM1 and its associated signaling pathway may be a potential target for therapeutic intervention for treatment of PTC. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2602. doi:10.1158/1538-7445.AM2011-2602
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2011
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...